PT95150A - Processo para a preparacao de uma composicao farmaceutica para a inversaao de atrofia da pele induzida por um glucocorticoide - Google Patents

Processo para a preparacao de uma composicao farmaceutica para a inversaao de atrofia da pele induzida por um glucocorticoide

Info

Publication number
PT95150A
PT95150A PT95150A PT9515090A PT95150A PT 95150 A PT95150 A PT 95150A PT 95150 A PT95150 A PT 95150A PT 9515090 A PT9515090 A PT 9515090A PT 95150 A PT95150 A PT 95150A
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
atrophy
glucocorticoide
reversal
preparing
Prior art date
Application number
PT95150A
Other languages
English (en)
Other versions
PT95150B (pt
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of PT95150A publication Critical patent/PT95150A/pt
Publication of PT95150B publication Critical patent/PT95150B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Pens And Brushes (AREA)
PT95150A 1989-08-31 1990-08-30 Processo para a preparacao de uma composicao farmaceutica para a inversaao de atrofia da pele induzida por um glucocorticoide PT95150B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/401,362 US5019569A (en) 1986-11-03 1989-08-31 Reversal of glucocorticoid-induced skin atrophy

Publications (2)

Publication Number Publication Date
PT95150A true PT95150A (pt) 1991-05-22
PT95150B PT95150B (pt) 1997-06-30

Family

ID=23587438

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95150A PT95150B (pt) 1989-08-31 1990-08-30 Processo para a preparacao de uma composicao farmaceutica para a inversaao de atrofia da pele induzida por um glucocorticoide

Country Status (13)

Country Link
US (1) US5019569A (pt)
EP (1) EP0415766B1 (pt)
JP (1) JP3061628B2 (pt)
AT (1) ATE147265T1 (pt)
AU (1) AU634807B2 (pt)
DE (1) DE69029625T2 (pt)
DK (1) DK0415766T3 (pt)
ES (1) ES2098253T3 (pt)
GR (1) GR1000723B (pt)
IE (1) IE903154A1 (pt)
PT (1) PT95150B (pt)
SG (1) SG50453A1 (pt)
ZA (1) ZA906931B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5268176A (en) * 1991-07-22 1993-12-07 Avon Products, Inc. Method and compositions for the non-invasive treatment of telangiectasia
EP0625045A4 (en) * 1992-02-07 1995-01-18 Albert M Kligman METHOD FOR TREATING FLAMMABLE DERMATOS.
EP0659080B1 (en) * 1992-09-11 2001-07-11 BROWN, Sandra Method for the treatment of hair loss
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
CA2129773C (en) 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US6380255B1 (en) 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
UA48212C2 (uk) * 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
FR2760362B1 (fr) 1997-03-10 2000-08-11 Vitasterol Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
NO326950B1 (no) * 2006-09-20 2009-03-16 Pharma Medico Res Ltd Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
CN108282998B (zh) 2015-06-18 2021-07-06 凡利亚药品北美公司 用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4126693A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
US4487782A (en) * 1982-03-26 1984-12-11 Ortho Pharmaceutical Corporation Topical treatment of non-inflammatory acne
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
EP0357646B1 (en) * 1987-04-06 1995-03-22 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
JP3061628B2 (ja) 2000-07-10
EP0415766B1 (en) 1997-01-08
US5019569A (en) 1991-05-28
AU6198790A (en) 1991-03-07
DE69029625D1 (de) 1997-02-20
DE69029625T2 (de) 1997-05-28
IE903154A1 (en) 1991-03-13
PT95150B (pt) 1997-06-30
SG50453A1 (en) 1998-07-20
GR1000723B (el) 1992-11-23
ATE147265T1 (de) 1997-01-15
JPH03141218A (ja) 1991-06-17
EP0415766A3 (en) 1992-04-08
ES2098253T3 (es) 1997-05-01
DK0415766T3 (da) 1997-01-27
GR900100644A (en) 1991-12-30
AU634807B2 (en) 1993-03-04
EP0415766A2 (en) 1991-03-06
ZA906931B (en) 1992-05-27

Similar Documents

Publication Publication Date Title
PT95150A (pt) Processo para a preparacao de uma composicao farmaceutica para a inversaao de atrofia da pele induzida por um glucocorticoide
PT89520B (pt) Processo para a preparacao de derivados de quinolino e acido naftiridino-carboxilicos substituidos por alquilo na posicao 5 e substituidos por um anel de piperazina ou pirrolidina na posicao 7 e de composicoes farmaceuticas que os contem
ATE84703T1 (de) Tocopherolsorbat enthaltende lichtschutzmittel.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
PT90197A (pt) Processo para a preparacao de uma composicao anti-inflamatoria hidratante para a pele
PT90198A (pt) Processo para a preparacao de uma composicao anti-inflamatoria hidratante para a pele
CO4520281A1 (es) Antifungicos de tetrahidrofurano
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
BR9100435A (pt) Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica
PT83459B (pt) Processo para a preparacao de composicoes farmaceuticas contendo o ester de 1-acetoxietilo da cefuroxima
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
PT90994A (pt) Processo para a preparacao de um sistema para a preparacao de composicoes para aplicacao topica
PT87190A (pt) Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
BR8704738A (pt) Compostos parasiticidas,processo para a sua preparacao e para tratamento e controle de infeccoes,processo para controlar insetos de plantas,e composicoes para esses tratamentos
PT773022E (pt) Preparacao farmaceutica para o tratamento de rinites agudas contendo simpaticomimeticos e pantotenol e/ou acido pantotenico
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
ATE78465T1 (de) Kathartica.
ES2134768T3 (es) Composicion farmaceutica que comprende un fosfoazucar.
BR9205077A (pt) Composicao para tratamento dos labios e processo para preparar a mesma
PT97088A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ipriflavona terapeuticamente uteis
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
PT95422A (pt) Processo para a preparacao de composicoes farmaceuticas para o tratamento de psoriase incorporando compostos de acidos alquilfosforicos
ES2103413T3 (es) Derivados del androstano sustituidos por un grupo amonio cuaternario en la posicion 16, composiciones farmaceuticas que los contienen y procedimientos para prepararlos.
BR9302809A (pt) Composto,processo para sua preparacao,processo de purificacao dos compostos,medicmanto,emprego e processo para a preparacao de um agente anti-tumoral

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901212

FG3A Patent granted, date of granting

Effective date: 19970321

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120321